126O - Olaparib as maintenance treatment following first-line platinum-based chemotherapy (PBC) in patients (pts) with a germline BRCA mutation and metastatic pancreatic cancer (mPC): Phase III POLO trial
| Autor: | Oh, D.-Y., Golan, T., Hammel, P., Reni, M., Van Cutsem, E., Macarulla, T., Hall, M.J., Park, J.O.H., Hochhauser, D., Arnold, D., Reinacher-Schick, A., Tortora, G., Algül, H., O'Reilly, E.M., McGuinness, D., Cui, K.Y., Schlienger, K., Locker, G.Y., Kindler, H.L. |
|---|---|
| Zdroj: | In Annals of Oncology November 2019 30 Supplement 9:ix44-ix45 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|